Lowest Price Guaranteed
Pages
325
Last Updated
June 2026
View Count
23808
1. BACKGROUND
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
2.5. Robust Quality Control
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Major Currencies Affecting the Market
4.2.2.2. Factors Affecting Currency Fluctuations on the Industry
4.2.2.3. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Currency Exchange Rate
4.2.3.1. Impact of Foreign Exchange Rate Volatility on the Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.4.2. Historical Analysis of Past Recessions and Lessons Learnt
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.8.3. Trade Policies
4.2.8.4. Strategies for Mitigating the Risks Associated with Trade Barriers
4.2.8.5. Impact of Trade Barriers on the Market
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. Stock Market Performance
4.2.11.7. Cross Border Dynamics
4.3. Conclusion
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Types of Ablation Techniques
6.3. Types of Catheter Ablation Techniques
6.3.1. Thermal Ablation Techniques
6.3.1.1. Radiofrequency Ablation
6.3.1.2. Laser Ablation
6.3.1.3. Microwave Ablation
6.3.1.4. Hydrothermal Ablation
6.3.1.5. High-Intensity Focused Ultrasound Ablation
6.3.2. Non-Thermal Ablation Techniques
6.3.2.1. Cryoablation
6.3.2.2. Mechanico-Chemical Ablation
6.3.2.3. Pulsed Field Ablation
6.4. Overview of Pulsed Field Ablation Therapy
6.4.1. Historical Evolution
6.4.2. Mechanism of Action
6.4.3. Therapeutic Applications
6.4.4. Advantages of Pulsed Field Ablation
6.5. Concluding Remarks
7. PULSED FIELD ABLATION DEVICES: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Pulsed Field Ablation Devices: Overall Market Landscape
7.2.1. Analysis by Product Components
7.2.2. Analysis by Shape of Catheter
7.2.3. Analysis by Configuration of Catheter
7.2.4. Analysis by Type of Catheter (by Irrigation)
7.2.5. Analysis by Catheter Shaft Diameter
7.2.6. Analysis by Number of Electrodes
7.2.7. Analysis by Electrical Polarity
7.2.8. Analysis by Source of Ablation
7.2.9. Analysis by Status of Development
7.2.10. Analysis by Application Area
7.2.11. Analysis by Status of Development and Location of Clinical Trial
7.2.12. Analysis by Target Therapeutic Area and Target Indication
7.2.13. Analysis by Status of Development and Target Therapeutic Area
7.2.14. Analysis by Location of Clinical Trial and Target Therapeutic Area
7.2.15. Analysis by Source of Ablation, Application Area, and Target Therapeutic Area
7.3. Pulsed Field Ablation Device Developers: Overall Market Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Analysis by Company Size and Location of Headquarters (Region)
7.3.5. Analysis by Type of Developer
7.3.6. Analysis by Company Ownership
7.3.7. Analysis by Company Ownership and Location of Headquarters (Region)
7.3.8. Most Active Players: Analysis by Number of Products
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Product Competitiveness Analysis: Pulsed Field Ablation Devices
8.4.1. Pulsed Field Ablation Devices Offered by Players based in North America
8.4.2. Pulsed Field Ablation Devices Offered by Players based in Europe
8.4.3. Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
8.5. Concluding Remarks
9. PULSED FIELD ABLATION DEVICE DEVELOPERS: DETAILED COMPANY PROFILES
9.1. Chapter Overview
9.2. Boston Scientific
9.2.1. Company Overview
9.2.2. Financial Information
9.2.3. Pulsed Field Ablation Portfolio
9.2.4. Recent Developments and Future Outlook
9.3. Medtronic
9.4. Galvanize Therapeutics
9.5. Pulse Biosciences
9.6. AngioDynamics
9.7. Biosense Webster
9.8. Acutus Medical
9.9. Kardium
10. PULSED FIELD ABLATION DEVICE DEVELOPERS: TABULATED PROFILES
10.1. Chapter Overview
10.2. Abbott
10.3. AccuPulse Medical
10.4. Argá Medtech
10.5. AtriAN Medical
10.6. AuriGen Medical
10.7. CathRx
10.8. ElectroPhysiology Frontiers
10.9. EnChannel Medical
10.10. Hangzhou Dinova EP Technology
10.11. Mirai Medical
10.12. Tianjin Intelligent Health Medical
11. RECENT DEVELOPMENTS AND INITIATIVES
11.1. Chapter Overview
11.2. Partnerships and Collaborations
11.2.1. Partnership Models
11.2.2. Pulsed Field Ablation: Partnerships and Collaborations
11.2.3. Analysis by Year of Partnership
11.2.4. Analysis by Type of Partnership
11.2.5. Analysis by Year and Type of Partnership
11.2.6. Analysis by Type of Product
11.2.7. Analysis by Type of Partnership and Type of Solution
11.2.8. Analysis by Therapeutic Area
11.2.9. Analysis by Type of Partnership and Therapeutic Area
11.2.10. Most Active Players: Analysis by Number of Partnerships
11.2.11. Analysis by Geography
11.2.11.1. Intercontinental and Intracontinental Agreements
11.2.11.2. Local and International Agreements
11.3. Funding and Investments
11.3.1. Funding Models
11.3.2. Pulsed Field Ablation: Funding and Investments
11.3.3. Analysis by Year of Investment
11.3.3.1. Cumulative Year-wise Trend of Funding Instances
11.3.3.2. Cumulative Year-wise Trend of Amount Invested
11.3.4. Analysis by Type of Funding
11.3.4.1. Analysis of Funding Instances
11.3.4.2. Analysis of Amount Invested
11.3.5. Analysis by Year and Type of Funding
11.3.5.1. Analysis of Funding Instances
11.3.5.2. Analysis of Amount Invested
11.3.6. Analysis of Funding Instances and Amount Invested by Therapeutic Area
11.3.7. Most Active Players: Analysis by Funding Instances
11.3.8. Most Active Players: Analysis by Amount Raised
11.3.9. Leading Investors: Analysis by Funding Instances
11.3.10. Analysis of Funding Instances and Amount Invested by Geography
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Pulsed Field Ablation: Patent Analysis
12.3.1. Analysis by Patent Application Year
12.3.2. Analysis by Patent Publication Year
12.3.3. Analysis by Type of Patent and Patent Publication Year
12.3.4. Analysis by Publication Time
12.3.5. Analysis by Patent Jurisdiction
12.3.6. Analysis by CPC Symbols
12.3.7. Analysis by Type of Applicant
12.3.8. Analysis by Patent Age
12.3.9. Leading Players: Analysis by Number of Patents
12.3.10. Leading Patent Assignees: Analysis by Number of Patents
12.4. Pulsed Field Ablation: Patent Benchmarking Analysis
12.4.1. Analysis of Top CPC Codes by Leading Industry Players
12.4.2. Analysis of Top CPC Codes by Publication Time
12.5. Pulsed Field Ablation: Patent Valuation
13. GLOBAL EVENTS ANALYSIS
13.1. Chapter Overview
13.2. Scope and Methodology
13.3. Pulsed Field Ablation: Global Events
13.3.1. Analysis by Year of Event
13.3.2. Analysis by Type of Event
13.3.3. Analysis by Year and Type of Event
13.3.4. Analysis by Event Platform
13.3.5. Analysis by Location of Event
13.3.6. Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
13.3.7. Most Active Event Organizers: Analysis by Number of Events
13.3.8. Most Active Players: Analysis by Number of Events
13.4. Global Events: Speaker Analysis
13.4.1. Most Active Speakers: Analysis by Number of Events
13.4.2. Analysis by Designation of Speakers
13.5. Concluding Remarks
14. CASE STUDY: POTENTIAL PARTNERS OF PULSED FIELD ABLATION DEVICE DEVELOPERS
14.1. Chapter Overview
14.2. Cardiac Mapping and Navigation Device Developers
14.2.1. Analysis by Year of Establishment
14.2.2. Analysis by Company Size
14.2.3. Analysis by Location of Headquarters
14.3. Likely Partner Analysis
14.3.1. Assumptions and Key Parameters
14.3.2. Methodology
14.4. Potential Strategic Partners for Cardiac Pulsed Field Ablation Device Developers
14.4.1. Cardiac Mapping and Navigation Device Developers: Most Likely Partners
14.4.2. Cardiac Mapping and Navigation Device Developers: Likely Partners
14.4.3. Cardiac Mapping and Navigation Device Developers: Less Likely Partners
15. MARKET IMPACT ANALYSIS
15.1. Chapter Overview
15.2. Market Drivers
15.3. Market Restraints
15.4. Market Opportunities
15.5. Market Challenges
15.6. Conclusion
16. GLOBAL PULSED FIELD ABLATION MARKET
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Pulsed Field Ablation Market, Historical Trends (Since 2018) and Future Estimates (Till 2035)
16.3.1. Scenario Analysis
16.3.1.1. Scenario I
16.3.1.2. Scenario III
16.4. Key Market Segmentations
16.5. Dynamic Dashboard
17. PULSED FIELD ABLATION MARKET, BY GEOGRAPHY
17.1. Chapter Overview
17.2. Forecast Methodology and Key Assumptions
17.3. North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.4. Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.5. Asia-Pacific: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
17.6. Data Triangulation
17.6.1. Insights from Secondary Research
17.6.2. Insights from In-house Repository
17.6.3. Dynamic Dashboard
18. PULSED FIELD ABLATION MARKET, BY THERAPEUTIC AREA
18.1. Chapter Overview
18.2. Forecast Methodology and Key Assumptions
18.3. Cardiovascular Disorders: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.4. Oncological Disorders: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.5. Respiratory Disorders: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.6. Dermatological Disorders: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
18.7. Data Triangulation
18.7.1. Insights from Secondary Research
18.7.2. Insights from In-house Repository
18.7.3. Dynamic Dashboard
19. PULSED FIELD ABLATION MARKET, BY PRODUCT COMPONENTS
19.1. Chapter Overview
19.2. Forecast Methodology and Key Assumptions
19.3. Catheters: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.4. Generators: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
19.5. Data Triangulation
19.5.1. Insights from Secondary Research
19.5.2. Insights from In-house Repository
19.5.3. Dynamic Dashboard
20. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY PRODUCT COMPONENTS
20.1. Chapter Overview
20.2. Forecast Methodology and Key Assumptions
20.3. Catheters: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
20.4. Generators: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
20.5. Data Triangulation
20.5.1. Insights from Secondary Research
20.5.2. Insights from In-house Repository
20.5.3. Dynamic Dashboard
21. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY APPLICATION AREA
21.1. Chapter Overview
21.2. Forecast Methodology and Key Assumptions
21.3. Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area
21.4. Pulsed Field Ablation Devices Market: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
21.5. Pulsed Field Ablation and Mapping Devices Market: Forecasted Estimates (Till 2035)
21.6. Data Triangulation
21.6.1. Insights from Secondary Research
21.6.2. Insights from In-house Repository
21.6.3. Dynamic Dashboard
22. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY SOURCE OF ABLATION
22.1. Chapter Overview
22.2. Forecast Methodology and Key Assumptions
22.3. Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation
22.4. Pulsed Field Energy: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
22.5. Pulsed Field and Radiofrequency Energy: Forecasted Estimates (Till 2035)
22.6. Pulsed Field Energy and Cryoablation: Forecasted Estimates (Till 2035)
22.7. Data Triangulation
22.7.1. Insights from Secondary Research
22.7.2. Insights from In-house Repository
22.7.3. Dynamic Dashboard
23. PULSED FIELD ABLATION MARKET FOR CARDIOVASCULAR DISORDERS, BY GEOGRAPHY
23.1. Chapter Overview
23.2. Forecast Methodology and Key Assumptions
23.3. Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Geography
23.4. Pulsed Field Ablation Market for Cardiovascular Disorders in North America: Forecasted Estimates (Till 2035)
23.4.1. Pulsed Field Ablation Market for Cardiovascular Disorders in the US: Forecasted Estimates (Till 2035)
23.4.2. Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Forecasted Estimates (Till 2035)
23.5. Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
23.6. Pulsed Field Ablation Market for Cardiovascular Disorders in Asia-Pacific: Forecasted Estimates (Till 2035)
23.6.1. Pulsed Field Ablation Market for Cardiovascular Disorders China: Forecasted Estimates (Till 2035)
23.6.2. Pulsed Field Ablation Market for Cardiovascular Disorders Japan: Forecasted Estimates (Till 2035)
23.7. Data Triangulation
23.7.1. Insights from Secondary Research
23.7.2. Insights from In-house Repository
23.7.3. Dynamic Dashboard
24. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY GEOGRAPHY
24.1. Chapter Overview
24.2. Forecast Methodology and Key Assumptions
24.3. Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography
24.4. North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
24.5. Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
24.6. Asia-Pacific: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
24.7. Data Triangulation
24.7.1. Insights from Secondary Research
24.7.2. Insights from In-house Repository
24.7.3. Dynamic Dashboard
25. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY PRODUCT COMPONENTS
25.1. Chapter Overview
25.2. Forecast Methodology and Key Assumptions
25.3. Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components
25.4. Catheters: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
25.5. Generators: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
25.6. Data Triangulation
25.6.1. Insights from Secondary Research
25.6.2. Insights from In-house Repository
25.6.3. Dynamic Dashboard
26. PULSED FIELD ABLATION MARKET FOR ONCOLOGICAL DISORDERS, BY TYPE OF CANCER
26.1. Chapter Overview
26.2. Forecast Methodology and Key Assumptions
26.3. Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer
26.4. Soft Tissue Ablative Cancers: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
26.5. Pancreatic Cancer: Forecasted Estimates (Till 2035)
26.6. Prostate Cancer: Forecasted Estimates (Till 2035)
26.7. Non-Small Cell Lung Cancer: Forecasted Estimates (Till 2035)
26.8. Esophageal Cancer: Forecasted Estimates (Till 2035)
26.9. Data Triangulation
26.9.1. Insights from Secondary Research
26.9.2. Insights from In-house Repository
26.9.3. Dynamic Dashboard
27. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY GEOGRAPHY
27.1. Chapter Overview
27.2. Forecast Methodology and Key Assumptions
27.3. North America: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
27.4. Europe: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
27.5. Asia-Pacific: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
27.6. Data Triangulation
27.6.1. Insights from Secondary Research
27.6.2. Insights from In-house Repository
27.6.3. Dynamic Dashboard
28. PULSED FIELD ABLATION MARKET FOR RESPIRATORY DISORDERS, BY PRODUCT COMPONENTS
28.1. Chapter Overview
28.2. Forecast Methodology and Key Assumptions
28.3. Catheters: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
28.4. Generators: Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
28.5. Data Triangulation
28.5.1. Insights from Secondary Research
28.5.2. Insights from In-house Repository
28.5.3. Dynamic Dashboard
29. PULSED FIELD ABLATION: SALES FORECAST OF LEADING PLAYERS
29.1. Chapter Overview
29.2. Boston Scientific: Pulsed Field Ablation Sales Forecast (Till 2035)
29.3. Medtronic: Pulsed Field Ablation Sales Forecast (Till 2035)
29.4. Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (Till 2035)
29.5. AngioDynamics: Pulsed Field Ablation Sales Forecast (Till 2035)
30. CONCLUDING REMARKS
31. EXECUTIVE INSIGHTS
31.1. Chapter Overview
31.2. Company A
31.2.1. Company Snapshot
31.2.2. Interview Transcript: Co-Founder and Chief Executive Officer, Small Company
31.3. Company B
31.3.1. Company Snapshot
31.3.2. Interview Transcript: Chief Medical Officer, Very Large Company
31.4. Company C
31.4.1. Company Snapshot
31.4.2. Interview Transcript: Chief of Cardiac Surgery and Co-Director, Very Large Company
31.5. Company D
31.5.1. Company Snapshot
31.5.2. Interview Transcript: Senior Vice President and President, Cardiac Rhythm Management & Diagnostics, Very Large Company
31.6. Company E
31.6.1. Company Snapshot
31.6.2. Interview Transcript: President, and Vice President of Preclinical and Clinical Research & Medical Affairs, Very Large Company
31.7. Company F
31.7.1. Company Snapshot
31.7.2. Interview Transcript: Managing Director, Large Company
31.8. Company G
31.8.1. Company Snapshot
31.8.2. Interview Transcript: Managing Director, Very Large Company
31.9. Company H
31.9.1. Company Snapshot
31.9.2. Interview Transcript: Director, Ventricular Tachycardia Program, Very Large Company
31.10. Company I
31.10.1. Company Snapshot
31.10.2. Interview Transcript: Co-Director, Translational Research & Research Fellowship, Very Large Company
31.11. Company I
31.11.1. Company Snapshot
31.11.2. Interview Transcript: Cardiologist, Very Large Company
32. APPENDIX 1: TABULATED DATA
33. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Research Methodology: Project Methodology
Figure 2.2 Research Methodology: Data Sources for Secondary Research
Figure 2.3 Research Methodology: Robust Quality Control
Figure 3.1 Market Dynamics: Forecast Methodology
Figure 3.2 Market Dynamics: Market Assessment Framework
Figure 4.1 Lessons Learnt from Past Recessions
Figure 5.1 Executive Summary: Market Landscape
Figure 5.2 Executive Summary: Recent Developments and Initiatives
Figure 5.3 Executive Summary: Patent Analysis
Figure 5.4 Executive Summary: Global Events Analysis
Figure 5.5 Executive Summary: Market Forecast and Opportunity Analysis
Figure 6.1 Types of Ablation Techniques
Figure 6.2 Steps Involved in Pulsed Field Ablation
Figure 6.3 Various Parameters related to Ablative Energy Delivery
Figure 6.4 Historical Evolution of Pulsed Field Ablation Therapy
Figure 6.5 Mechanism of Action: Steps of Irreversible Electroporation
Figure 6.6 Advantages of Pulsed Field Ablation
Figure 7.1 Pulsed Field Ablation Devices: Distribution by Product Components
Figure 7.2 Pulsed Field Ablation Devices: Distribution by Shape of Catheter
Figure 7.3 Pulsed Field Ablation Devices: Distribution by Configuration of Catheter
Figure 7.4 Pulsed Field Ablation Devices: Distribution by Type of Catheter (by Irrigation)
Figure 7.5 Pulsed Field Ablation Devices: Distribution by Catheter Shaft Diameter (in Fr)
Figure 7.6 Pulsed Field Ablation Devices: Distribution by Number of Electrodes
Figure 7.7 Pulsed Field Ablation Devices: Distribution by Electrical Polarity
Figure 7.8 Pulsed Field Ablation Devices: Distribution by Source of Ablation
Figure 7.9 Pulsed Field Ablation Devices: Distribution by Status of Development
Figure 7.10 Pulsed Field Ablation Devices: Distribution by Status of Development and Location of Clinical Trial
Figure 7.11 Pulsed Field Ablation Devices: Distribution by Application Area
Figure 7.12 Pulsed Field Ablation Devices: Distribution by Target Therapeutic Area and Target Indication
Figure 7.13 Pulsed Field Ablation Devices: Distribution by Status of Development and Target Therapeutic Area
Figure 7.14 Pulsed Field Ablation Devices: Distribution by Location of Clinical Trial and Target Therapeutic Area
Figure 7.15 Pulsed Field Ablation Devices: Distribution by Source of Ablation, Application Area and Target Therapeutic Area
Figure 7.16 Pulsed Field Ablation Device Developers: Distribution by Year of Establishment
Figure 7.17 Pulsed Field Ablation Device Developers: Distribution by Company Size
Figure 7.18 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Region)
Figure 7.19 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Country)
Figure 7.20 Pulsed Field Ablation Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Figure 7.21 Pulsed Field Ablation Device Developers: Distribution by Type of Developer
Figure 7.22 Pulsed Field Ablation Device Developers: Distribution by Company Ownership
Figure 7.23 Pulsed Field Ablation Device Developers: Distribution by Company Ownership and Location of Headquarters (Region)
Figure 7.24 Most Active Players: Distribution by Number of Products
Figure 8.1 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in North America
Figure 8.2 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Europe
Figure 8.3 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
Figure 8.4 Product Competitiveness Analysis of Pulsed Field Ablation Devices: Competitiveness Score of Top Products
Figure 9.1 Boston Scientific: Financial Information
Figure 9.2 Medtronic: Financial Information
Figure 9.3 AngioDynamics: Financial Information
Figure 9.4 Acutus Medical: Financial Information
Figure 11.1 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2022
Figure 11.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 11.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 11.4 Partnerships and Collaborations: Distribution by Type of Product
Figure 11.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Figure 11.6 Partnerships and Collaborations: Distribution by Therapeutic Area
Figure 11.7 Partnerships and Collaborations: Distribution by Type of Partnership and Therapeutic Area
Figure 11.8 Most Active Players: Distribution by Number of Partnerships
Figure 11.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 11.10 Partnerships and Collaborations: Local and International Agreements
Figure 11.11 Funding and Investments: Cumulative Year-wise Trend of Funding Instances, Since 2022
Figure 11.12 Funding and Investments: Cumulative Year-wise Trend of Amount Invested, Since 2022
Figure 11.13 Funding and Investments: Distribution of Funding Instances by Type of Funding
Figure 11.14 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 11.15 Funding and Investments: Distribution of Funding Instances by Year and Type of Funding
Figure 11.16 Funding and Investments: Distribution of Amount Invested by Year and Type of Funding (USD Million)
Figure 11.17 Funding and Investments: Distribution of Funding Instances and Amount Invested by Therapeutic Area
Figure 11.18 Most Active Players: Distribution by Funding Instances
Figure 11.19 Most Active Players: Distribution by Amount Raised
Figure 11.20 Leading Investors: Distribution by Funding Instances
Figure 11.21 Funding and Investments: Distribution of Funding Instances and Amount Invested by Geography
Figure 12.1 Patent Analysis: Distribution by Type of Patent
Figure 12.2 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Since 2022
Figure 12.3 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, Since 2022
Figure 12.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Figure 12.5 Patent Analysis: Distribution by Publication Time
Figure 12.6 Patent Analysis: Distribution by Patent Jurisdiction
Figure 12.7 Patent Analysis: Distribution by Type of Applicant
Figure 12.8 Patent Analysis: Distribution by Patent Age
Figure 12.9 Leading Players: Distribution by Number of Patents
Figure 12.10 Leading Patent Assignees: Distribution by Number of Patents
Figure 12.11 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) Leading Industry Players
Figure 12.12 Patent Benchmarking Analysis: Distribution of Patent Characteristics (CPC Codes) by Publication Time
Figure 12.13 Pulsed Field Ablation Devices: Patent Valuation
Figure 13.1 Global Events Analysis: Cumulative Year-wise Trend, Since 2022
Figure 13.2 Global Events Analysis: Distribution by Type of Event
Figure 13.3 Global Events Analysis: Distribution by Year and Type of Event
Figure 13.4 Global Events Analysis: Distribution by Event Platform
Figure 13.5 Global Events Analysis: Distribution by Location of Event (Region)
Figure 13.6 Global Events Analysis: Distribution by Location of Event (Country)
Figure 13.7 Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
Figure 13.8 Most Active Event Organizers: Distribution by Number of Events
Figure 13.9 Most Active Players: Distribution by Number of Events
Figure 13.10 Most Active Speakers: Distribution by Number of Events
Figure 13.11 Distribution by Designations of Speakers
Figure 14.1 Cardiac Mapping and Navigation Device Developers: Distribution by Year of Establishment
Figure 14.2 Cardiac Mapping and Navigation Device Developers: Distribution by Company Size
Figure 14.3 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Region)
Figure 14.4 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Country)
Figure 14.5 Cardiac Mapping and Navigation Device Developers: Likely Partners of Cardiac Pulsed Field Ablation Device Developers
Figure 16.1 Global Pulsed Field Ablation Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Million)
Figure 16.2 Global Pulsed Field Ablation Market, Forecasted Estimates (Till 2035), Scenario I (USD Million)
Figure 16.3 Global Pulsed Field Ablation Market, Forecasted Estimates (Till 2035), Scenario II (USD Million)
Figure 16.4 Global Pulsed Field Ablation Market, Forecasted Estimates (Till 2035), Scenario III (USD Million)
Figure 16.5 Global Pulsed Field Ablation Market (Dynamic Dashboard Snippet)
Figure 17.1 Pulsed Field Ablation Market: Distribution by Geography
Figure 17.2 Pulsed Field Ablation Market in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million
Figure 17.3 Pulsed Field Ablation Market in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 17.4 Pulsed Field Ablation Market in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 17.5 Pulsed Field Ablation Market: Distribution by Geography (Dynamic Dashboard Snippet)
Figure 18.1 Pulsed Field Ablation Market: Distribution by Therapeutic Area
Figure 18.2 Pulsed Field Ablation Market for Cardiovascular Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 18.3 Pulsed Field Ablation Market for Oncological Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 18.4 Pulsed Field Ablation Market for Respiratory Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 18.5 Pulsed Field Ablation Market for Dermatological Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 18.6 Pulsed Field Ablation Market: Distribution by Therapeutic Area (Dynamic Dashboard Snippet)
Figure 19.1 Pulsed Field Ablation Market: Distribution by Product Components
Figure 19.2 Pulsed Field Ablation Market for Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 19.3 Pulsed Field Ablation Market for Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 19.4 Pulsed Field Ablation Market: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 20.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Product Components
Figure 20.2 Pulsed Field Ablation Market for Cardiovascular Disorders using Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 20.3 Pulsed Field Ablation Market for Cardiovascular Disorders using Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 20.4 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 21.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area
Figure 21.2 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 21.3 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation and Mapping Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 21.4 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area (Dynamic Dashboard Snippet)
Figure 22.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation
Figure 22.2 Pulsed Field Ablation Market for Cardiovascular Disorders using PF Energy-based Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 22.3 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and RF Energy-based Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 22.4 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and Cryo Energy-based Devices, Historical Trends (Since 2018) and Forecasted Estimates(Till 2035) (USD Million)
Figure 22.5 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation (Dynamic Dashboard Snippet)
Figure 23.1 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Geography
Figure 23.2 Pulsed Field Ablation Market for Cardiovascular Disorders in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.3 Pulsed Field Ablation Market for Cardiovascular Disorders in US, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.4 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.5 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates(Till 2035) (USD Million)
Figure 23.6 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.7 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.8 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.9 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.10 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.11 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.12 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.13 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.14 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.15 Pulsed Field Ablation Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.16 Pulsed Field Ablation Market for Cardiovascular Disorders in China, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.17 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.18 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.19 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.20 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.21 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.22 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.23 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 23.24 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Region (Dynamic Dashboard Snippet)
Figure 24.1 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography
Figure 24.2 Pulsed Field Ablation Market for Oncological Disorders in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 24.3 Pulsed Field Ablation Market for Oncological Disorders in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 24.4 Pulsed Field Ablation Market for Oncological Disorders in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 24.5 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography (Dynamic Dashboard Snippet)
Figure 25.1 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components
Figure 25.2 Pulsed Field Ablation Market for Oncological Disorders using Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 25.3 Pulsed Field Ablation Market for Oncological Disorders using Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 25.4 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 26.1 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer
Figure 26.2 Pulsed Field Ablation Market for Soft-tissue Ablative Cancers, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 26.3 Pulsed Field Ablation Market for Pancreatic Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 26.4 Pulsed Field Ablation Market for Prostate Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 26.5 Pulsed Field Ablation Market for Non-Small Cell Lung Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 26.6 Pulsed Field Ablation Market for Esophageal Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 26.7 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer (Dynamic Dashboard Snippet)
Figure 27.1 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Geography
Figure 27.2 Pulsed Field Ablation Market for Respiratory Disorders in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 27.3 Pulsed Field Ablation Market for Respiratory Disorders in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 27.4 Pulsed Field Ablation Market for Respiratory Disorders in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 27.5 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Geography (Dynamic Dashboard Snippet)
Figure 28.1 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Product Components
Figure 28.2 Pulsed Field Ablation Market for Respiratory Disorders using Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 28.3 Pulsed Field Ablation Market for Respiratory Disorders using Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Figure 28.4 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Product Components (Dynamic Dashboard Snippet)
Figure 29.1 Boston Scientific: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Figure 29.2 Medtronic: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Figure 29.3 Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Figure 29.4 AngioDynamics: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Figure 30.1 Concluding Remarks: Overall Market Landscape
Figure 30.2 Concluding Remarks: Recent Developments
Figure 30.3 Concluding Remarks: Patent Analysis
Figure 30.4 Concluding Remarks: Global Events Analysis
Figure 30.5 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 6.1 Differences between Catheter Ablation and Surgical Ablation
Table 6.2 Types of Catheter Ablation Techniques: Information on Mechanism of Action, Advantages and Disadvantages
Table 7.1 List of Pulsed Field Ablation Devices
Table 7.2 Pulsed Field Ablation Devices: Information on Shape of Catheter, Configuration of Catheter and Type of Catheter (by Irrigation)
Table 7.3 Pulsed Field Ablation Devices: Information on Catheter Shaft Diameter, Number of Electrodes and Electrical Polarity
Table 7.4 Pulsed Field Ablation Devices: Information on Source of Ablation, Status of Development, Phase of Development of Investigational Devices and Application
Table 7.5 Pulsed Field Ablation Devices: Information on NCT Number and Location of Clinical Trial
Table 7.6 Pulsed Field Ablation Devices: Information on Target Indication and Target Therapeutic Area
Table 7.7 List of Pulsed Field Ablation Device Developers
Table 9.1 Leading Developers of Pulsed Field Ablation Systems
Table 9.2 Boston Scientific: Company Snapshot
Table 9.3 Boston Scientific: Pulsed Field Ablation Portfolio
Table 9.4 Boston Scientific: Recent Developments and Future Outlook
Table 9.5 Medtronic: Company Snapshot
Table 9.6 Medtronic: Pulsed Field Ablation Portfolio
Table 9.7 Medtronic: Recent Developments and Future Outlook
Table 9.8 Galvanize Therapeutics: Company Snapshot
Table 9.9 Galvanize Therapeutics: Pulsed Field Ablation Portfolio
Table 9.10 Galvanize Therapeutics: Recent Developments and Future Outlook
Table 9.11 Pulse Biosciences: Company Snapshot
Table 9.12 Pulse Biosciences: Pulsed Field Ablation Portfolio
Table 9.13 Pulse Biosciences: Recent Developments and Future Outlook
Table 9.14 AngioDynamics: Company Snapshot
Table 9.15 AngioDynamics: Pulsed Field Ablation Portfolio
Table 9.16 AngioDynamics: Recent Developments and Future Outlook
Table 9.17 Biosense Webster: Company Snapshot
Table 9.18 Biosense Webster: Pulsed Field Ablation Portfolio
Table 9.19 Biosense Webster: Recent Developments and Future Outlook
Table 9.20 Acutus Medical: Company Snapshot
Table 9.21 Acutus Medical: Pulsed Field Ablation Portfolio
Table 9.22 Acutus Medical: Recent Developments and Future Outlook
Table 9.23 Kardium: Company Snapshot
Table 9.24 Kardium: Pulsed Field Ablation Portfolio
Table 9.25 Kardium: Recent Developments and Future Outlook
Table 10.1 Abbott: Company Snapshot and Product Portfolio
Table 10.2 AccuPulse Medical: Company Snapshot and Product Portfolio
Table 10.3 Argá Medtech: Company Snapshot and Product Portfolio
Table 10.4 AtriAN Medical: Company Snapshot and Product Portfolio
Table 10.5 AuriGen Medical: Company Snapshot and Product Portfolio
Table 10.6 CathRx: Company Snapshot and Product Portfolio
Table 10.7 ElectroPhysiology Frontiers: Company Snapshot and Product Portfolio
Table 10.8 EnChannel Medical: Company Snapshot and Product Portfolio
Table 10.9 Hangzhou Dinova EP Technology: Company Snapshot and Product Portfolio
Table 10.10 Mirai Medical: Company Snapshot and Product Portfolio
Table 10.11 Tianjin Intelligent Health Medical: Company Snapshot and Product Portfolio
Table 11.1 Pulsed Field Ablation: List of Partnerships and Collaborations
Table 11.2 Pulsed Field Ablation: List of Funding and Investments
Table 12.1 Patent Analysis: Top CPC Sections
Table 12.2 Patent Analysis: Top CPC Symbols
Table 12.3 Patent Analysis: Top CPC Codes
Table 12.4 Patent Analysis: Summary of Benchmarking Analysis
Table 12.5 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 12.6 Patent Analysis: List of Leading Patents (by Number of Citations)
Table 13.1 Pulsed Field Ablation: List of Global Events
Table 14.1 List of Cardiac Mapping and Navigation Device Developers
Table 14.2 Likely Partner Analysis: Cardiac Mapping and Navigation Device Developers
Table 33.1 Pulsed Field Ablation Devices: Distribution by Product Components
Table 33.2 Pulsed Field Ablation Devices: Distribution by Shape of Catheter
Table 33.3 Pulsed Field Ablation Devices: Distribution by Configuration of Catheter
Table 33.4 Pulsed Field Ablation Devices: Distribution by Type of Catheter (by Irrigation)
Table 33.5 Pulsed Field Ablation Devices: Distribution by Catheter Shaft Diameter (in Fr)
Table 33.6 Pulsed Field Ablation Devices: Distribution by Number of Electrodes
Table 33.7 Pulsed Field Ablation Devices: Distribution by Electrical Polarity
Table 33.8 Pulsed Field Ablation Devices: Distribution by Source of Ablation
Table 33.9 Pulsed Field Ablation Devices: Distribution by Status of Development
Table 33.10 Pulsed Field Ablation Devices: Distribution by Status of Development and Location of Clinical Trial
Table 33.11 Pulsed Field Ablation Devices: Distribution by Application Area
Table 33.12 Pulsed Field Ablation Devices: Distribution by Target Therapeutic Area and Target Indication
Table 33.13 Pulsed Field Ablation Devices: Distribution by Status of Development and Target Therapeutic Area
Table 33.14 Pulsed Field Ablation Devices: Distribution by Location of Clinical Trial and Target Therapeutic Area
Table 33.15 Pulsed Field Ablation Devices: Distribution by Source of Ablation, Application Area and Target Therapeutic Area
Table 33.16 Pulsed Field Ablation Device Developers: Distribution by Year of Establishment
Table 33.17 Pulsed Field Ablation Device Developers: Distribution by Company Size
Table 33.18 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Region)
Table 33.19 Pulsed Field Ablation Device Developers: Distribution by Location of Headquarters (Country)
Table 33.20 Pulsed Field Ablation Device Developers: Distribution by Company Size and Location of Headquarters (Region)
Table 33.21 Pulsed Field Ablation Device Developers: Distribution by Type of Developer
Table 33.22 Pulsed Field Ablation Device Developers: Distribution by Company Ownership
Table 33.23 Pulsed Field Ablation Device Developers: Distribution by Company Ownership and Location of Headquarters (Region)
Table 33.24 Most Active Players: Distribution by Number of Products
Table 33.25 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in North America
Table 33.26 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Europe
Table 33.27 Product Competitiveness Analysis: Pulsed Field Ablation Devices Offered by Players based in Asia-Pacific
Table 33.28 Product Competitiveness Analysis of Pulsed Field Ablation Devices: Competitiveness Score of Top Products
Table 33.29 Boston Scientific: Financial Information
Table 33.30 Medtronic: Financial Information
Table 33.31 AngioDynamics: Financial Information
Table 33.32 Acutus Medical: Financial Information
Table 33.33 Partnerships and Collaborations: Cumulative Year-wise Trend, Since 2022
Table 33.34 Partnerships and Collaborations: Distribution by Type of Partnership
Table 33.35 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 33.36 Partnerships and Collaborations: Distribution by Type of Product
Table 33.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Product
Table 33.38 Partnerships and Collaborations: Distribution by Therapeutic Area
Table 33.39 Partnerships and Collaborations: Distribution by Type of Partnership and Therapeutic Area
Table 33.40 Most Active Players: Distribution by Number of Partnerships
Table 33.41 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 33.42 Partnerships and Collaborations: Local and International Agreements
Table 33.43 Funding and Investments: Cumulative Year-wise Trend of Funding Instances, Since 2022
Table 33.44 Funding and Investments: Cumulative Year-wise Trend of Amount Invested, Since 2022
Table 33.45 Funding and Investments: Distribution of Funding Instances by Type of Funding
Table 33.46 Funding and Investments: Distribution of Amount Invested by Type of Funding (USD Million)
Table 33.47 Funding and Investments: Distribution of Funding Instances by Year and Type of Funding
Table 33.48 Funding and Investments: Distribution of Amount Invested by Year and Type of Funding (USD Million)
Table 33.49 Funding and Investments: Distribution of Funding Instances and Amount Invested by Therapeutic Area
Table 33.50 Most Active Players: Distribution by Funding Instances
Table 33.51 Most Active Players: Distribution by Amount Raised
Table 33.52 Leading Investors: Distribution by Funding Instances
Table 33.53 Funding and Investments: Distribution of Funding Instances and Amount Invested by Geography
Table 33.54 Patent Analysis: Distribution by Type of Patent
Table 33.55 Patent Analysis: Cumulative Year-wise Trend by Patent Application Year, Since 2022
Table 33.56 Patent Analysis: Cumulative Year-wise Trend by Patent Publication Year, Since 2022
Table 33.57 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Table 33.58 Patent Analysis: Distribution by Publication Time
Table 33.59 Patent Analysis: Distribution by Patent Jurisdiction
Table 33.60 Patent Analysis: Distribution by Type of Applicant
Table 33.61 Patent Analysis: Distribution by Patent Age
Table 33.62 Leading Players: Distribution by Number of Patents
Table 33.63 Leading Patent Assignees: Distribution by Number of Patents
Table 33.64 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)
Table 33.65 Patent Benchmarking Analysis: Distribution of Publication Time by Patent Characteristics (CPC Codes)
Table 33.66 Pulsed Field Ablation: Patent Valuation
Table 33.67 Global Events Analysis: Cumulative Year-wise Trend, Since 2018
Table 33.68 Global Events Analysis: Distribution by Type of Event
Table 33.69 Global Events Analysis: Distribution by Year and Type of Event
Table 33.70 Global Events Analysis: Distribution by Event Platform
Table 33.71 Global Events Analysis: Distribution by Location of Event (Region)
Table 33.72 Global Events Analysis: Distribution by Location of Event (Country)
Table 33.73 Word Cloud Analysis: Evolutionary Trends in Event Agenda / Key Focus Areas
Table 33.74 Most Active Event Organizers: Distribution by Number of Events
Table 33.75 Most Active Participants: Distribution by Number of Events
Table 33.76 Most Active Speakers: Distribution by Number of Events
Table 33.77 Distribution by Designations of Speakers
Table 33.78 Cardiac Mapping and Navigation Device Developers: Distribution by Year of Establishment
Table 33.79 Cardiac Mapping and Navigation Device Developers: Distribution by Company Size
Table 33.80 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Region)
Table 33.81 Cardiac Mapping and Navigation Device Developers: Distribution by Location of Headquarters (Country)
Table 33.82 Cardiac Mapping and Navigation Device Developers: Likely Partners of Cardiac Pulsed Field Ablation Device Developers
Table 33.83 Global Pulsed Field Ablation Market, Historical Trends (Since 2018) and Future Estimates (Till 2035) (USD Million)
Table 33.84 Global Pulsed Field Ablation Market, Forecasted Estimates (Till 2035), Scenario I (USD Million)
Table 33.85 Global Pulsed Field Ablation Market, Forecasted Estimates (Till 2035), Scenario II (USD Million)
Table 33.86 Global Pulsed Field Ablation Market, Forecasted Estimates (Till 2035), Scenario III (USD Million)
Table 33.87 Pulsed Field Ablation Market: Distribution by Geography
Table 33.88 Pulsed Field Ablation Market in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.89 Pulsed Field Ablation Market in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.90 Pulsed Field Ablation Market in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.91 Pulsed Field Ablation Market: Distribution by Therapeutic Area
Table 33.92 Pulsed Field Ablation Market for Cardiovascular Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.93 Pulsed Field Ablation Market for Oncological Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.94 Pulsed Field Ablation Market for Respiratory Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.95 Pulsed Field Ablation Market for Dermatological Disorders, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.96 Pulsed Field Ablation Market: Distribution by Product Components
Table 33.97 Pulsed Field Ablation Market for Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.98 Pulsed Field Ablation Market for Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.99 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Product Components
Table 33.100 Pulsed Field Ablation Market for Cardiovascular Disorders using Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.101 Pulsed Field Ablation Market for Cardiovascular Disorders using Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.102 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Application Area
Table 33.103 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035)
Table 33.104 Pulsed Field Ablation Market for Cardiovascular Disorders using Ablation and Mapping Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.105 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Source of Ablation
Table 33.106 Pulsed Field Ablation Market for Cardiovascular Disorders using PF Energy-based Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.107 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and RF Energy-based Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.108 Pulsed Field Ablation Market for Cardiovascular Disorders using PF and Cryo Energy-based Devices, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.109 Pulsed Field Ablation Market for Cardiovascular Disorders: Distribution by Geography
Table 33.110 Pulsed Field Ablation Market for Cardiovascular Disorders in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.111 Pulsed Field Ablation Market for Cardiovascular Disorders in US, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.112 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.113 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.114 Pulsed Field Ablation Market for Cardiovascular Disorders in US: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.115 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.116 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.117 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.118 Pulsed Field Ablation Market for Cardiovascular Disorders in Canada: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.119 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.120 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.121 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.122 Pulsed Field Ablation Market for Cardiovascular Disorders in Europe: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.123 Pulsed Field Ablation Market for Cardiovascular Disorders in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.124 Pulsed Field Ablation Market for Cardiovascular Disorders in China, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.125 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.126 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.127 Pulsed Field Ablation Market for Cardiovascular Disorders in China: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.128 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.129 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Product Components, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.130 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Application Area, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.131 Pulsed Field Ablation Market for Cardiovascular Disorders in Japan: Distribution by Source of Ablation, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.132 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Geography
Table 33.133 Pulsed Field Ablation Market for Oncological Disorders in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.134 Pulsed Field Ablation Market for Oncological Disorders in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.135 Pulsed Field Ablation Market for Oncological Disorders in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.136 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Product Components
Table 33.137 Pulsed Field Ablation Market for Oncological Disorders using Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.138 Pulsed Field Ablation Market for Oncological Disorders using Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.139 Pulsed Field Ablation Market for Oncological Disorders: Distribution by Type of Cancer
Table 33.140 Pulsed Field Ablation Market for Soft-tissue Ablative Cancers, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.141 Pulsed Field Ablation Market for Pancreatic Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.142 Pulsed Field Ablation Market for Prostate Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.143 Pulsed Field Ablation Market for Non-Small Cell Lung Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.144 Pulsed Field Ablation Market for Esophageal Cancer, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.145 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Geography
Table 33.146 Pulsed Field Ablation Market for Respiratory Disorders in North America, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.147 Pulsed Field Ablation Market for Respiratory Disorders in Europe, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.148 Pulsed Field Ablation Market for Respiratory Disorders in Asia-Pacific, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.149 Pulsed Field Ablation Market for Respiratory Disorders: Distribution by Product Components
Table 33.150 Pulsed Field Ablation Market for Respiratory Disorders using Catheters, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.151 Pulsed Field Ablation Market for Respiratory Disorders using Generators, Historical Trends (Since 2018) and Forecasted Estimates (Till 2035) (USD Million)
Table 33.152 Boston Scientific: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Table 33.153 Medtronic: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Table 33.154 Galvanize Therapeutics: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)
Table 33.155 AngioDynamics: Pulsed Field Ablation Sales Forecast (Till 2035) (USD Million)